Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer

af Jove, Maria, Vilariño, Noelia, Nadal, Ernest
Udgivet i Transl Lung Cancer Res (2019)

PD-L1 expression testing in non-small cell lung cancer

af Teixidó, Cristina, Vilariño, Noelia, Reyes, Roxana, Reguart, Noemí
Udgivet i Ther Adv Med Oncol (2018)

Induction treatment in patients with stage III non-small cell lung cancer

af Palmero, Ramón, Vilariño, Noelia, Navarro-Martín, Arturo, Nadal, Ernest
Udgivet i Transl Lung Cancer Res (2021)

Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients

af Remon, Jordi, Mezquita, Laura, Corral, Jesús, Vilariño, Noelia, Reguart, Noemi
Udgivet i J Thorac Dis (2018)

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors

af Vilariño, Noelia, Bruna, Jordi, Kalofonou, Foteini, Anastopoulou, Garifallia G., Argyriou, Andreas A.
Udgivet i Int J Mol Sci (2020)

Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study

af Alemany, Montse, Domènech, Marta, Argyriou, Andreas A., Vilariño, Noelia, Majós, Carles, Naval-Baudin, Pablo, Lucas, Anna, Palmero, Ramón, Simó, Marta, Nadal, Ernest, Bruna, Jordi
Udgivet i Ann Transl Med (2021)

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors

af Arribas, Lorena, Plana, Maria, Taberna, Miren, Sospedra, Maria, Vilariño, Noelia, Oliva, Marc, Pallarés, Natalia, González Tampán, Ana Regina, Del Rio, Luis Miguel, Mesia, Ricard, Baracos, Vickie
Udgivet i Front Oncol (2021)